RT @aHUSAllianceAct: Long-term observational study of atypical HUS patients of varied ages, N=93. Notes discontinuation of #eculizumab nee…
Little info available re long-term studies on #patients w/ the #RareDisease atypical HUS. Collaboration of in'tl #aHUS expert #clinician /researchers look at N=93 re #genetics, #diagnosis, treatment, #complement, more. #DataDriven #PersonalizedMedicine h
RT aHUSAllianceAct Long-term observational study of atypical HUS patients of varied ages, N=93. Notes discontinuation of #eculizumab needs careful monitoring of #aHUS patients for organ function & risk factors for relapse, inc #genetics, age of onset,
Long-term observational study of atypical HUS patients of varied ages, N=93. Notes discontinuation of #eculizumab needs careful monitoring of #aHUS patients for organ function & risk factors for relapse, inc #genetics, age of onset, and #TMA episodes.